This company researches and manufactures pharmaceutical, bio-therapeutic, and diagnostic products and has specialized in immunology and hematology. It was_established in DATE and has its registered office_located in CITY,_COUNTRY. The company operates in NUMBER_segments_: Plasma Proteins, Microbiological Monitoring, and Biotherapeutics. Its plasma proteins segment researches, develops,_manufactures, and distributes CRIMINAL_CHARGE on the basis of human blood plasma that_are_used to_treat CAUSE_OF_DEATH of the immune or haemopoietic systems. Its microbiological monitoring segment develops,_produces, and markets reagents, devices, and systems used in hygiene monitoring for air, surface, and manufacturing processes, as_well_as procedures to test end products for potential microorganism contamination. The company 's biotherapeutics segment involves in the research,_development, and production of monoclonal antibodies, including for the treatment of rheumatoid arthritis and CAUSE_OF_DEATH_CAUSE_OF_DEATH. The company is considered NUMBER of the leading_manufacturers of products for the hygiene monitoring of air and work surfaces, as_well_as NUMBER of the world_'s_leading specialists in immunology and hematology. It has operating_subsidiaries in COUNTRY,_COUNTRY,_COUNTRY, the COUNTRY COUNTRY,_COUNTRY,_COUNTRY,_COUNTRY, COUNTRY,_COUNTRY,_COUNTRY, COUNTRY COUNTRY, and COUNTRY.